RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%

    NEXT STORY
    Immunoassay in R&D Market Value to Surpass USD 7,716.6 Million Revenue Mark by 2023 at 8.18 % CAGR, Says Market Research Future
    PREV STORY
    G1 Therapeutics Appoints Mark Avagliano as Chief Business Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Bavarian Nordic Announces Interim Results for the First Three Months of 2018

    COPENHAGEN, Denmark, May 24, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

    author_avatar
    NASDAQ Market News

    Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting

    REDWOOD CITY, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified ...

    author_avatar
    NASDAQ Market News

    Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards

    Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards   Consistent ...

    author_avatar
    NASDAQ Market News